BusinessIGC Files International Patents for IGC-501 Compound Indicated for Neuropathic PainBy Nasdaq OMXApr 10, 2017, 10:00 AM UTC
BusinessIGC’s CEO to Participate as Panelist at NY CPA Society Marijuana SymposiumBy Nasdaq OMXDec 13, 2016, 11:00 AM UTC
BusinessETST Announces 60-Patient Clinical Prelaunch Study for its MSN-2 Medical Device for the Diagnosis of Chlamydia & Gonorrhea, ETST Elects Dr. Michel Aubé as New CEO & CSO, and Nickolas Tabraue as President.By Nasdaq OMXNov 21, 2016, 1:15 PM UTC
